FDA Approved: ZIMHI — Original Application (ZMI Pharma Inc.)

View source ↗

Summary

FDA approved the original application for ZIMHI, a naloxone hydrochloride injection, by ZMI Pharma Inc., for emergency treatment of opioid overdose.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Overdose

Drugs mentioned

• ZIMHI (Naloxone hydrochloride)

Snippet

ORIG AP for ZIMHI (NALOXONE HYDROCHLORIDE)